Incidence, epidemiology and treatment results of osteosarcoma in Finland – a nationwide population-based study

References

• Fletcher CDM, Unri KK, Mertens F. WHO classification of tumors pathology and genetics tumors of soft tissue and bone. 1st. Lyon: IARC Press; 2002.
   Google Scholar
• Huvos AG. In: Bone tumors. Diagnosis, treatment and prognosis. 2nd. Philadelphia: W.B. Saunders; 1991.
   Google Scholar
• Smeland S, Muller C, Alvegard TA, Wiklund T, Wiebe T, Bjork O, . Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: Prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003;39:488–94.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, . Neoadjuvant chemotherapy with high- dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005;23:8845–52.
   PubMed Web of Science ®Google Scholar
• Harvei S, Solheim O. The prognosis in osteosarcoma: Norwegian National Data. Cancer 1981;48:1719–23.
   PubMed Web of Science ®Google Scholar
• Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365–9.
   PubMed Web of Science ®Google Scholar
• Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980;153:106–20.
   PubMed Web of Science ®Google Scholar
• Fagioli F, Aglietta M, Tienghi A, Ferrari S, Brach del Prever A, Vassallo E, . High-dose chemotherapy in the treatment of relapsed osteosarcoma: An Italian sarcoma group study. J Clin Oncol 2002;20:2150–6.
   PubMed Web of Science ®Google Scholar
• Brach Del Prever A, Smeland S, Tienghi A, Hall KS, Aglietta M, Bernini G, . High-risk osteosarcoma (OS): Preliminary results of the ISG-SSG II protocol. J Clin Oncol, 2005 ASCO Annual Meeting Proceedings. 2005; 23:9002.
   Web of Science ®Google Scholar
• Smeland S, Bruland OS, Hjorth L, Brosjo O, Bjerkehagen B, Osterlundh G, . Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma. Acta Orthop 2011;82:211–6.
   PubMed Web of Science ®Google Scholar
• Larsson SE, Lorentzon R. The incidence of malignant primary bone tumours in relation to age, sex and site. A study of osteogenic sarcoma, chondrosarcoma and Ewing’s sarcoma diagnosed in Sweden from 1958 to 1968. J Bone Joint Surg Br 1974;56B:534–40.
   PubMedGoogle Scholar
• Curry H, Horne G, Devane P, Tobin H. Osteosarcoma in New Zealand: An outcome study comparing survival rates between 1981–1987 and 1994–1999. N Z Med J 2006;119: U2234.
   PubMedGoogle Scholar
• Stiller CA, Passmore SJ, Kroll ME, Brownbill PA, Wallis JC, Craft AW. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980–1994. Br J Cancer 2006;94:22–9.
   PubMed Web of Science ®Google Scholar
• Sampo MM, Tarkkanen M, Kivioja AH, Taskinen MH, Sankila R, Bohling TO. Osteosarcoma in Finland from 1971 through 1990: A nationwide study of epidemiology and outcome. Acta Orthop 2008;79:861–6.
   PubMed Web of Science ®Google Scholar
• Picci P, Mercuri M, Ferrari S, Alberghini M, Briccoli A, Ferrari C, . Survival in high-grade osteosarcoma: Improvement over 21 years at a single institution. Ann Oncol 2010;21:1366–73.
   PubMed Web of Science ®Google Scholar
• Eyre R, Feltbower RG, James PW, Blakey K, Mubwandarikwa E, Forman D, . The epidemiology of bone cancer in 0–39 year olds in northern England, 1981–2002. BMC Cancer 2010;10:357.
   PubMed Web of Science ®Google Scholar
• Briccoli A, Rocca M, Salone M, Guzzardella GA, Balladelli A, Bacci G. High grade osteosarcoma of the extremities metastatic to the lung: Long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005. Surg Oncol 2010;19:193–9.
   PubMed Web of Science ®Google Scholar
• Ward WG, Mikaelian K, Dorey F, Mirra JM, Sassoon A, Holmes EC, . Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 1994;12:1849–58.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Bacci G, Picci P, Mercuri M, Briccoli A, Pinto D, . Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol 1997;8: 765–71.
   PubMed Web of Science ®Google Scholar
• Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, . Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol 1992;10:5–15.
   PubMed Web of Science ®Google Scholar
• Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, Hogendoorn PC, . Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007;99:112–28.
   PubMed Web of Science ®Google Scholar